Lv3
340 积分 2024-03-21 加入
Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis
1个月前
已完结
Pimavanserin for bipolar disorder
1个月前
已完结
5-HT 2A and 5-HT 2C receptor antagonism differentially modulate reinforcement learning and cognitive flexibility: behavioural and computational evidence
1个月前
已完结
Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis
1个月前
已完结
Pimavanserin tartrate: a 5-HT2A inverse agonist with potential for treating various neuropsychiatric disorders
1个月前
已完结
Pimavanserin exhibits serotonin 5-HT2A receptor inverse agonism for Gαi1- and neutral antagonism for Gαq/11-proteins in human brain cortex
1个月前
已完结
Imaging the 5-HT2C receptor with PET: evaluation of 5-HT2C and 5-HT2A affinity of pimavanserin in the primate brain
1个月前
已完结
Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial
1个月前
已完结
Lithium and Tamoxifen Modulate Behavior and Protein Kinase C Activity in the Animal Model of Mania Induced by Ouabain
1个月前
已完结
皖公网安备34019202002308
